Bristol-Myers Squibb Company (BMY)

NYQ – Real Time Price. Currency in USD

63.73

+0.12 (0.19%)

Market open: Aug 12, 2026, 10:13 AM EDT

63.99

+0.38 (0.59%)

Previous after-hours: Aug 11, 2026, 7:59 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

48.19B

48.30B

45.01B

46.16B

Cost of goods sold

-16.44B

-20.87B

-19.65B

-19.67B

Gross Profit

31.76B

27.43B

25.36B

26.49B

Operating expenses (excl. COGS)

-16.64B

-17.77B

-16.89B

-17.22B

Operating Income

15.12B

9.66B

8.47B

9.27B

Non-operating income, total

-5.79B

-18.04B

-32M

-1.56B

Pretax income

9.33B

-8.38B

8.44B

7.71B

Equity in earnings

Taxes

-2.27B

-554M

-400M

-1.37B

Non-controlling/minority interest

-2M

-15M

-18M

After tax other income/expense

Net income before discontinued operations

7.05B

-8.95B

8.03B

6.33B

Discontinued operations

Net income

7.05B

-8.95B

8.03B

6.33B

Dilution adjustment

Preferred dividends

Bristol-Myers Squibb Company (BMY)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Bristol-Myers Squibb Company (BMY)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Bristol-Myers Squibb Company (BMY)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Bristol-Myers Squibb Company (BMY)

Income Statement (Annual)

Income Statement (Annual)